118 related articles for article (PubMed ID: 6262880)
1. Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: a study by high pressure liquid chromatography.
Deschodt-Lanckman M; Bui ND; Noyer M; Christophe J
Regul Pept; 1981 Apr; 2(1):15-30. PubMed ID: 6262880
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin octa- and tetrapeptide degradation by synaptic membranes. I. Evidence for competition with enkephalins for in vitro common degradation pathways.
Deschodt-Lanckman M; Bui ND
Peptides; 1981; 2 Suppl 2():113-8. PubMed ID: 6283489
[TBL] [Abstract][Full Text] [Related]
3. Degradation of cholecystokinin octapeptide, related fragments and analogs by human and rat plasma in vitro.
Koulischer D; Moroder L; Deschodt-Lanckman M
Regul Pept; 1982 Aug; 4(3):127-39. PubMed ID: 6291099
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin octa- and tetrapeptide degradation by synaptic membranes. III. Inactivation of CCK-8 by a phosphoramidon-sensitive endopeptidase.
Deschodt-Lanckman M; Koulischer D; Przedborski S; Lauwereys M
Peptides; 1984; 5(3):649-51. PubMed ID: 6089150
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
[TBL] [Abstract][Full Text] [Related]
6. Products of cholecystokinin (CCK)-octapeptide proteolysis interact with central CCK receptors.
Steardo L; Knight M; Tamminga CA; Chase TN
Neurosci Lett; 1985 Mar; 54(2-3):319-25. PubMed ID: 2986058
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
[TBL] [Abstract][Full Text] [Related]
8. Conformational analysis of possible biologically active (receptor-bound) conformations of peptides derived from cholecystokinin, cerulein and little gastrin and the opiate peptide, Met-enkephalin.
Pincus MR; Murphy RB; Carty RP; Chen J; Shah D; Scheraga HA
Peptides; 1988; 9 Suppl 1():145-52. PubMed ID: 2856638
[TBL] [Abstract][Full Text] [Related]
9. Novel activity of angiotensin-converting enzyme. Hydrolysis of cholecystokinin and gastrin analogues with release of the amidated C-terminal dipeptide.
Dubreuil P; Fulcrand P; Rodriguez M; Fulcrand H; Laur J; Martinez J
Biochem J; 1989 Aug; 262(1):125-30. PubMed ID: 2554881
[TBL] [Abstract][Full Text] [Related]
10. High affinity binding of cholecystokinin to small cell lung cancer cells.
Yoder DG; Moody TW
Peptides; 1987; 8(1):103-7. PubMed ID: 3033616
[TBL] [Abstract][Full Text] [Related]
11. Degradation of a tetragastrin analogue by a membrane fraction from rat gastric mucosa.
Dubreuil P; Lignon MF; Magous R; Rodriguez M; Bali JP; Martinez J
Drug Des Deliv; 1987 Sep; 2(1):49-54. PubMed ID: 3509344
[TBL] [Abstract][Full Text] [Related]
12. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
Corringer PJ; Weng JH; Ducos B; Durieux C; Boudeau P; Bohme A; Roques BP
J Med Chem; 1993 Jan; 36(1):166-72. PubMed ID: 8421283
[TBL] [Abstract][Full Text] [Related]
13. Cyclic cholecystokinin analogues with high selectivity for central receptors.
Charpentier B; Pelaprat D; Durieux C; Dor A; Reibaud M; Blanchard JC; Roques BP
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1968-72. PubMed ID: 3162318
[TBL] [Abstract][Full Text] [Related]
14. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
[TBL] [Abstract][Full Text] [Related]
15. Binding specificity of the mouse cerebral cortex receptor for small cholecystokinin peptides.
Steigerwalt RW; Williams JA
Regul Pept; 1984 Jan; 8(1):51-9. PubMed ID: 6326203
[TBL] [Abstract][Full Text] [Related]
16. Enzyme-resistant CCK analogs with high affinities for central receptors.
Charpentier B; Durieux C; Pelaprat D; Dor A; Reibaud M; Blanchard JC; Roques BP
Peptides; 1988; 9(4):835-41. PubMed ID: 3226959
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and binding affinities of analogues of cholecystokinin-(30-33) as probes for central nervous system cholecystokinin receptors.
Horwell DC; Beeby A; Clark CR; Hughes J
J Med Chem; 1987 Apr; 30(4):729-32. PubMed ID: 3560164
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological studies on CCKB receptors in guinea pig synaptoneurosomes.
Galas MC; Bernad N; Martinez J
Eur J Pharmacol; 1992 May; 226(1):35-41. PubMed ID: 1327841
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cholecystokinin binding sites in rat cerebral cortex using a 125I-CCK-8 probe resistant to degradation.
Praissman M; Martinez PA; Saladino CF; Berkowitz JM; Steggles AW; Finkelstein JA
J Neurochem; 1983 May; 40(5):1406-13. PubMed ID: 6300335
[TBL] [Abstract][Full Text] [Related]
20. On the biologically active structures of cholecystokinin, little gastrin, and enkephalin in the gastrointestinal system.
Pincus MR; Carty RP; Chen J; Lubowsky J; Avitable M; Shah D; Scheraga HA; Murphy RB
Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4821-5. PubMed ID: 3037525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
